Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT07382739
Recruiting
A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT07455851
Recruiting
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Phase 1/2 · Australia, Greece · 9 sites
Registry update: 5 Nov 2026
NCT07255898
Recruiting
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
Phase 1 · China · 1 site
Registry update: 4 Jun 2026
NCT07777406
Recruiting
Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma
Not applicable · Italy · 1 site
Registry update: 20 Aug 2026
NCT07181941
Recruiting
Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
Phase 1/2 · United States · 1 site
Registry update: 16 Sept 2026
NCT07200102
Recruiting
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
Phase 1 · United States · 1 site
Registry update: 15 Oct 2026
NCT07529782
Recruiting
Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 · China · 5 sites
Registry update: 14 Apr 2026
NCT07751783
Recruiting
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
Not applicable · Taiwan · 1 site
Registry update: 7 Aug 2026
NCT07452198
Recruiting
A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 · China · 1 site
Registry update: 25 Mar 2026
NCT07085728
Recruiting
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
Phase 2 · United States · 1 site
Registry update: 14 Sept 2026
NCT07429721
Recruiting
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
Early phase 1 · China · 1 site
Registry update: 22 Jul 2026
NCT07523555
Recruiting
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
Phase 1/2 · China · 1 site
Registry update: 13 Apr 2026
NCT07409246
Recruiting
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Phase 1 · China, Israel, Japan, United States · 14 sites
Registry update: 20 Oct 2026
NCT07454382
Recruiting
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Phase 2 · United States · 7 sites
Registry update: 16 Jun 2026
NCT07456605
Recruiting
Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma
Phase 1 · Canada · 1 site
Registry update: 12 Jun 2026
NCT07391657
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Phase 3 · Australia, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Italy, Japan, South Korea, Norway, Poland, Taiwan, United States · 117 sites
Registry update: 29 Sept 2026
NCT07284758
Recruiting
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Phase 2 · Spain, France, United Kingdom, Italy, Poland, United States · 62 sites
Registry update: 30 Oct 2026
NCT07342179
Recruiting
CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)
Not applicable · France · 1 site
Registry update: 18 Feb 2026
NCT07376733
Recruiting
Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma
Not applicable · Spain · 1 site
Registry update: 1 Oct 2026
NCT07290309
Recruiting
Survivors Uniting for Remote Guided Exercise
Not applicable · United States · 1 site
Registry update: 31 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.